Loss of EBP50 stimulates EGFR activity to induce EMT phenotypic features in biliary cancer cells

Oncogene

Volumn 31, Issue 11, 2012, Pages 1376-1388

  Claperon A ^a,b   Guedj, N ^c   Mergey, M ^a,b   Vignjevic, D ^d   Desbois Mouthon, C ^a,b   Boissan, M ^a,b,e   Saubamea B ^a   Paradis, V ^c   Housset, C ^a,b   Fouassier, L ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c BEAUJON HOSPITAL   (France)

^d INSTITUT CURIE   (France)

^e HÔPITAL TENON   (France)

Author keywords

adherens junctions; biliary carcinoma; cell motility; EGFR; NHERF 1

Indexed keywords

CALVASCULIN; CYTOKERATIN 19; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN; PROTEIN EZRIN RADIXIN MOESIN BINDING PHOSPHOPROTEIN 50; SMALL INTERFERING RNA; STAT3 PROTEIN; TRANSCRIPTION FACTOR SLUG; UNCLASSIFIED DRUG; UVOMORULIN;

ARTICLE; BILE DUCT CARCINOMA; CANCER LOCALIZATION; CARCINOGENESIS; CARCINOMA CELL; CELL MEMBRANE; CELL MOTILITY; CELL POLARITY; CELL SURFACE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DOWNSTREAM PROCESSING; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LAMELLIPODIUM; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; SATELLITE CELL; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

BILIARY TRACT NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CHOLANGIOCARCINOMA; CYTOPLASM; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; PHOSPHOPROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SODIUM-HYDROGEN ANTIPORTER;

EID: 84858341592     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.334     Document Type: Article

References (36)

1. Bhattacharyya RP, Remenyi A, Yeh BJ, Lim WA. (2006). Domains, motifs, and scaffolds: The role of modular interactions in the evolution and wiring of cell signaling circuits. Annu Rev Biochem 75: 655-680.
2. Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'aquila ME, Casavola V et al. (2007). The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 18: 1768-1780.
3. Chen H, Zhu G, Li Y, Padia RN, Dong Z, Pan ZK et al. (2009). Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression. Cancer Res 69: 9228-9235.
4. Claperon A, Therrien M. (2007). KSR and CNK: Two scaffolds regulating RAS-mediated RAF activation. Oncogene 26: 3143-3158.
5. Cortese MS, Uversky VN, Dunker AK. (2008). Intrinsic disorder in scaffold proteins: Getting more from less. Prog Biophys Mol Biol 98: 85-106.
6. Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI. (2007). Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 177: 893-903.
7. Dard N, Peter M. (2006). Scaffold proteins in MAP kinase signaling: More than simple passive activating platforms. BioEssays 28: 146-156.
8. Finzi L, Shao MX, Paye F, Housset C, Nadel JA. (2009). Lipopolysaccharide initiates a positive feedback of epidermal growth factor receptor signaling by prostaglandin E2 in human biliary carcinoma cells. J Immunol 182: 2269-2276.
9. Fouassier L, Duan CY, Feranchak AP, Yun CH, Sutherland E, Simon F et al. (2001). Ezrin-radixin-moesin-binding phosphoprotein 50 is expressed at the apical membrane of rat liver epithelia. Hepatology 33: 166-176.
10. Fouassier L, Rosenberg P, Mergey M, Saubamea B, Claperon A, Kinnman N et al. (2009). Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation. Am J Pathol 174: 869-880.
11. Georgescu MM, Morales FC, Molina JR, Hayashi Y. (2008). Roles of NHERF1/EBP50 in cancer. Curr Mol Med 8: 459-468.
12. Guedj N, Zhan Q, Perigny M, Rautou PE, Degos F, Belghiti J et al. (2009). Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. J Hepatol 51: 93-101.
13. Hayashi Y, Molina JR, Hamilton SR, Georgescu MM. (2010). NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia 12: 1013-1022.
14. Henson ES, Gibson SB. (2006). Surviving cell death through epidermal growth factor (EGF) signal transduction pathways: Implications for cancer therapy. Cell Signal 18: 2089-2097.
15. Hoque MT, Cole SP. (2008). Down-regulation of Na+/H+ exchanger regulatory factor 1 increases expression and function of multidrug resistance protein 4. Cancer Res 68: 4802-4809.
16. Knuth A, Gabbert H, Dippold W, Klein O, Sachsse W, Bitter- Suermann D et al. (1985). Biliary adenocarcinoma. Characterisation of three new human tumor cell lines. J Hepatol 1: 579-596.
17. Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu TJ et al. (2007). Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 26: 5290-5299.
18. Lambertini E, Franceschetti T, Torreggiani E, Penolazzi L, Pastore A, Pelucchi S et al. (2010). SLUG: A new target of lymphoid enhancer factor-1 in human osteoblasts. BMC Mol Biol 11: 13.
19. Lazar CS, Cresson CM, Lauffenburger DA, Gill GN. (2004). The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface. Mol Biol Cell 15: 5470-5480.
20. Lee CH, Hung HW, Hung PH, Shieh YS. (2010). Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer. Mol Cancer 9: 64.
21. Li M, Wang W, Soroka CJ, Mennone A, Harry K, Weiman EJ et al. (2010). NHERF-1 binds to Mrp2 and regulates hepatic Mrp2 expression and function. J Biol Chem 85: 19299-19307.
22. Lo HW, Hsu SC, Xia W, Cao X, Shih JY, Wei Y et al. (2007). Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67: 9066-9076.
23. Masuda M, Kikuchi S, Maruyama T, Sakurai-Yageta M, Williams YN, Ghosh HP et al. (2005). Tumor suppressor in lung cancer (TSLC)1 suppresses epithelial cell scattering and tubulogenesis. J Biol Chem 280: 42164-42171.
24. Molina JR, Morales FC, Hayashi Y, Aldape KD, Georgescu MM. (2010). Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation. Cancer Res 70: 6697-6703.
25. Murthy A, Gonzalez-Agost iC, Cordero E, Pinney D, Candia C, Solomon F et al. (1998). NHE-RF, a regulatory cofactor for Na(+)-H+ exchange, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem 273: 1273-1276.
26. Reczek D, Berryman M, Bretscher A. (1997). Identification of EBP50: A PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 139: 169-179.
27. Sebastian S, Settleman J, Reshkin SJ, Azzariti A, Bellizzi A, Paradiso A. (2006). The complexity of targeting EGFR signalling in cancer: From expression to turnover. Biochim Biophys Acta 1766: 120-139.
28. Shibata T, Chuma M, Kokubu A, Sakamoto M, Hirohashi S. (2003). EBP50, a beta-catenin-Associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 38: 178-186.
29. Song J, Bai J, Yang W, Gabrielson EW, Chan DW, Zhang Z. (2007). Expression and clinicopathological significance of oestrogenresponsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. Histopathology 51: 40-53.
30. Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP, James M, Pinney-Michalowski D, Roy JE et al. (2001). NHE-RF, a merlininteracting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol 158: 57-62.
31. Takahashi Y, Morales FC, Kreimann EL, Georgescu MM. (2006). PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 25: 910-920.
32. Vondriska TM, Pass JM, Ping P. (2004). Scaffold proteins and assembly of multiprotein signaling complexes. J Mol Cell Cardiol 37: 391-397.
33. Weinman EJ, Steplock D, Shenolikar S. (1993). cAMP-mediated inhibition of the renal brush border membrane Na+-H+ exchanger requires a dissociable phosphoprotein cofactor. J Clin Invest 92: 1781-1786.
34. Werneburg NW, Yoon JH, Higuchi H, Gores GJ. (2003). Bile acids activate EGF receptor via a TGF-Alpha-dependent mechanism in human cholangiocyte cell lines. Am J Physiol Gastrointest Liver Physiol 285: G31-G36.
35. Yoon JH, Gwak GY, Lee HS, Bronk SF, Werneburg NW, Gores GJ. (2004). Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells. J Hepatol 41: 808-814.
36. Yoshikawa D, Ojima H, Iwasaki M, Hiraoka N, Kosuge T, Kasai S et al. (2008). Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma. Br J Cancer 98: 418-425.